🇺🇸 FDA
Company

LIXTE

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT biotech USA

Quick answer

LIXTE is a biotech company (LIXT) headquartered in BOCA RATON, FL, USA with 3 tracked pipeline programs.

Pipeline (3)

project

Dostarlimab

Ovarian Clear Cell Carcinoma

Phase 2 · small_molecule · active

1 trials project

LB-100

Myelodysplastic Syndromes

Phase 2 · small_molecule · active

1 trials project

LB-100 for Injection

Tumors

Phase 1 · small_molecule · completed

1 trials

Patents (8)

patent

US 12343342

Methods for treating soft tissue sarcoma

Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11931354

Formulations of oxabicycloheptanes and oxabicycloheptenes

Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11866444

Oxabicycloheptane prodrugs

Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11236102

Oxabicycloheptane prodrugs

Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10668062

Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10618908

Oxabicycloheptane prodrugs

Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10532050

Formulations of oxabicycloheptanes and oxabicycloheptenes

Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10434100

Protein phosphatase 2A inhibitors for treating myelodysplastic syndromes

Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)